Retaglutide is a novel GLP-1 receptor agonist currently under research for the treatment of obesity. This therapy works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://teganmctp415790.blogripley.com/39767723/semaglutide-a-potential-solution-for-metabolic-disorders